InterMark provides strategic international market entry and clinical consulting services to the medical technology industry. Our consulting services are designed to help clients expand into new markets, manage clinical trials,  identify potential partners, and provide concept to commercialization services.

The management team has developed an expertise in the rapidly expanding field of cellular therapies and regenerative medicine.   They are among the first to have successfully commercialized an autologous cell therapy platform in the UK and other EU countries.

Utilizing proven methodologies and "Best Practices", InterMark focuses on clinical, regulatory,  and business development consulting projects to clients worldwide. These projects include:  clinical trial management,  market strategy development, and international market entry services.